Published in J Clin Microbiol on May 01, 1980
Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiol Rev (1996) 6.97
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Differentiation of Campylobacter and Campylobacter-like organisms by cellular fatty acid composition. J Clin Microbiol (1987) 3.93
Identification methods for campylobacters, helicobacters, and related organisms. Clin Microbiol Rev (1996) 3.32
Isoprenoid quinone content and cellular fatty acid composition of Campylobacter species. J Clin Microbiol (1984) 3.06
Illness associated with Campylobacter laridis, a newly recognized Campylobacter species. J Clin Microbiol (1985) 3.00
Applications of cellular fatty acid analysis. Clin Microbiol Rev (1991) 2.72
Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States. J Clin Microbiol (1987) 2.59
Hippurate hydrolysis by and triphenyltetrazolium tolerance of Campylobacter fetus. J Clin Microbiol (1982) 1.82
Clonal nature of Campylobacter fetus as defined by multilocus sequence typing. J Clin Microbiol (2005) 1.36
Evidence that the Campylobacter fetus sap locus is an ancient genomic constituent with origins before mammals and reptiles diverged. Infect Immun (2001) 1.14
Ileocolitis associated with Anaerobiospirillum in cats. J Clin Microbiol (2004) 0.88
The cellular fatty acid composition of Campylobacter species isolated from cases of enteritis in man and animals. J Hyg (Lond) (1986) 0.84
Campylobacter enteritis: a "new" disease. Br Med J (1977) 34.77
Campylobacter enteritis. Clin Gastroenterol (1979) 18.67
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
The genus Campylobacter. Annu Rev Microbiol (1978) 10.89
Mass spectrometry in lipid research. J Lipid Res (1960) 4.82
Cellular fatty acids and metabolic products of Pseudomonas species obtained from clinical specimens. J Clin Microbiol (1976) 3.94
Campylobacter infections in human beings. J Pediatr (1979) 3.72
A simple procedure for detecting the presence of cyclopropane fatty acids in bacterial lipids. Appl Microbiol (1968) 2.92
Identification of Achromobacter species by cellular fatty acids and by production of keto acids. J Clin Microbiol (1978) 2.90
Comparison of rapid methods for analysis of bacterial fatty acids. Appl Microbiol (1974) 2.63
Synthesis of the hydroxyacids in lipid A of Pseudomonas aeruginosa. J Gen Microbiol (1972) 1.14
Chromatographic studies of the lipid components of Vibrio fetus. Biochim Biophys Acta (1971) 1.14
Degradation of bacterial cyclopropane acids with boron trihalide reagents. Microbios (1977) 1.12
Detection of Legionnaires disease bacteria by direct immunofluorescent staining. J Clin Microbiol (1978) 17.69
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Primary isolation media for Legionnaires disease bacterium. J Clin Microbiol (1978) 11.86
Cellular fatty acid composition of isolates from Legionnaires disease. J Clin Microbiol (1977) 10.84
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57
Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol (1980) 10.44
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Campylobacter enteritis. N Engl J Med (1981) 7.98
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol (1976) 7.48
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Cultural and chemical characterization of CDC groups EO-2, M-5, and M-6, Moraxella (Moraxella) species, Oligella urethralis, Acinetobacter species, and Psychrobacter immobilis. J Clin Microbiol (1988) 5.97
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Characterization of clostridia by gas chromatography. I. Differentiation of species by cellular fatty acids. Appl Microbiol (1967) 5.41
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Gas-liquid chromatography as an analytical tool in microbiology. J Chromatogr (1981) 5.12
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol (1993) 5.06
Recognition of a new serogroup of Legionnaires disease bacterium. J Clin Microbiol (1979) 5.02
Identification of microorganisms by gas chromatographic-mass spectrometric analysis of cellular fatty acids. J Chromatogr (1975) 4.64
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
The epidemiology of Helicobacter pylori infection. Epidemiol Rev (1991) 4.40
A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis (1988) 4.28
Non-cholera vibrio infections in the United States. Clinical, epidemiologic, and laboratory features. Ann Intern Med (1978) 4.28
Cellular fatty acids of Alcaligenes and Pseudomonas species isolated from clinical specimens. J Clin Microbiol (1975) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
The rickettsia-like organisms TATLOCK (1943) and HEBA (1959): bacteria phenotypically similar to but genetically distinct from Legionella pneumophila and the WIGA bacterium. Ann Intern Med (1980) 3.96
Cellular fatty acids and metabolic products of Pseudomonas species obtained from clinical specimens. J Clin Microbiol (1976) 3.94
Differentiation of Campylobacter and Campylobacter-like organisms by cellular fatty acid composition. J Clin Microbiol (1987) 3.93
Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens. J Clin Microbiol (1979) 3.86
Legionella longbeachae species nova, another etiologic agent of human pneumonia. Ann Intern Med (1981) 3.78
Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol (1995) 3.63
Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations. Clin Infect Dis (1992) 3.61
Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol (1989) 3.59
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Unidentified gram-negative rod infection. A new disease of man. Ann Intern Med (1977) 3.53
Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
Cellular fatty acid composition of selected Pseudomonas species. Appl Microbiol (1972) 3.28
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen. Rev Infect Dis (1983) 3.23
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Pseudomonas putrefaciens isolates from clinical specimens. Appl Microbiol (1972) 3.21
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Occurrence of branched-cahin hydroxy fatty acids in Pseudomonas maltophilia. J Bacteriol (1973) 3.16
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Gas-liquid chromatography of bacterial fatty acids with a fused-silica capillary column. J Clin Microbiol (1980) 3.11
Identification of Vibrio hollisae sp. nov. from patients with diarrhea. J Clin Microbiol (1982) 3.08
A newly identified bacterium phenotypically resembling, but genetically distinct from, Legionella pneumophila: an isolate in a case of pneumonia. Ann Intern Med (1979) 3.08
Isoprenoid quinone content and cellular fatty acid composition of Campylobacter species. J Clin Microbiol (1984) 3.06
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Mycobacterium celatum sp. nov. Int J Syst Bacteriol (1993) 2.97
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Isoprenoid quinones of the genus Legionella. J Clin Microbiol (1982) 2.94
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Identification of Achromobacter species by cellular fatty acids and by production of keto acids. J Clin Microbiol (1978) 2.90
Reservoirs for human campylobacteriosis. J Infect Dis (1980) 2.87
Cultural characteristics and fatty acid composition of propionibacteria. J Bacteriol (1969) 2.87
Detection of Listeria monocytogenes by using the polymerase chain reaction. Appl Environ Microbiol (1990) 2.84
Release of biologically active peptides from Escherichia coli at subzero temperatures. J Bacteriol (1966) 2.83
Cultural characteristics and fatty acid composition of Corynebacterium acnes. J Bacteriol (1967) 2.83
Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun (1987) 2.82
"Endotoxicity" of the Legionnaires' disease bacterium. Ann Intern Med (1979) 2.78
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1999) 2.77
Identification of nutritional components in trypticase responsible for recovery of Escherichia coli injured by freezing. J Bacteriol (1966) 2.76
Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis (1985) 2.71
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol (1998) 2.65